Sławomir Majewski’s research team


Sławomir Majewski’s research team


  • prof. Sławomir Majewski, MD, PhD

Group leader bibliometrics
(Sławomir Majewski)

Impact Factor:
(Google Scholar) 4 150
H-index (Google Scholar):

Team leaders biograms

Prof. Slawomir Majewski, M.D., PhD. Head of the Department of Dermatology and Venereology, Medical University of Warsaw, specialist in dermatology, verereology, and alergology.  Deputy Rector for Science and International Relations at the MUW. Coordinator of the CePT project. Holder of the Alexander von Humboldt Scholarship (Department of Dermatology and Institute of Immunology, University of Munich, Germany – 1990-1991); visiting professor at the Unite des Papillomavirus, Institut Pasteur, Paris – 1992 (CNRS).

Member of several national and international societies and scientific institutions including Polish Academy of Sciences, European Society of Dermatological Research, European Academy of Dermatology and Venereology, European Association for Cancer Research,  American Association for Cancer Research, International Advisory Committee of the Archives of Dermatology, International Editorial Committee of the Journal of American Academy of Dermatology, Board Member of European Society for Dermatological Research (ESDR) 2000-2004 . Deputy Secretary of the Section of Medical Sciences of the Polish Academy of Sciences 1996-2010).

Author or co-author of 370 papers (citation index  – 4150, cumulative impact factor without abstracts – 420, h-index = 34).

Main scientific interests: immunopathogenesis and treatment of psoriasis, pathogenesis and treatment of allergic skin diseases, the role of immune system in control of HPV (human papillomavirus) infections of the skin and mucosa as well as in the progression of HPV-associated tumors; molecular and cellular mechanisms of HPV-associated cancerogenesis; mechanisms regulating tumor-induced angiogenesis and the effects of anti-angiogenic compounds; new treatment modalities of genital and skin cancer, UV-associated cutaneous cancerogenesis. Since 2003 member of the International Steering Committee of the FUTURE II Study on the quadrivalent HPV vaccine.